Metabolic & Endocrine
Polycystic Ovarian Syndrome
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Polycystic Ovarian Syndrome is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
31
clinical trials
Completed18 · 58%
Unknown status7 · 23%
Not yet recruiting3 · 10%
Terminated1 · 3%
Recruiting1 · 3%
Withdrawn1 · 3%
Clinical Trials
Trial Activity
31 trials
Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients
Not yet recruiting·—·Phase 3·NCT06405243·100 enrolled
Adjuvant Therapy With Letrozole in Induction of Ovulation With Polycystic Ovarian Syndrome
Not yet recruiting·—·Phase 3·NCT06405178·500 enrolled
Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate
Not yet recruiting·—·N/A·NCT07379502·60 enrolled
Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome.
Completed·—·Phase 3·NCT02304107·140 enrolled
Clomiphene Stair-Step Protocol for Ovulation Induction in Women With Polycystic Ovarian Syndrome
Completed·—·N/A·NCT01953796·140 enrolled
Study to Assess the Effect of Metformin Supplementation on IVF Outcome in Patients With Polycystic Ovarian Syndrome.
Completed·—·Phase 3·NCT03086005·24 enrolled
Letrozole or Combined Clomiphene Citrate Metformin as a First Line Treatment in Women With Polycystic Ovarian Syndrome
Completed·—·N/A·NCT01679574·200 enrolled
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome
Completed·—·N/A·NCT06812559·100 enrolled
The Efficacy and Safety Study of Tung's Acupuncture for Polycystic Ovarian Syndrome
Completed·—·Phase 2·NCT02729545·60 enrolled
Serum Anti-mullerian Hormone and Polycystic Ovarian Syndrome
Completed·—·Phase 2·NCT03237312·50 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)